ICON Eyecare participates in several national clinical research trials in an effort to enrich and develop better treatment options for our patients for a variety of medical ophthalmic conditions and diseases including glaucoma, dry eye, and cataracts.
If you are interested in learning more or participating in any of our ongoing clinical research trials, please contact Chris Bosch, Clinical Research Coordinator at 970.205.9555 or Chris.Bosch@iconeyecare.com.
‘NEXPEDE-1’ by Amber Ophthalmics, Inc.: For individuals at least 2 years of age with persistent Epithelial Defects
‘Rayner’ by Rayner Surgical, Inc.: For adults 22+ with Cataracts AND Astigmatism
‘iStar’ by iSTAR Medical: For adults 46+ with glaucoma AND who have had cataract surgery at least 1 year ago
‘Infinite’ by Glaukos: For adults with glaucoma or ocular hypertension
‘VVN461’ by VivaVision Biotech, Inc.: For adults 21+ with cataracts
Check back for more details on upcoming clinical research trials.